Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice.
In this study, we have established conditions for generating Leishmania amazonensis recombinants stably expressing the firefly luciferase gene. These parasites produced significant bioluminescent signals for both in vitro studies and the development of an in vivo model, allowing the course of the parasitism to be readily monitored in real time in the living animals such as laboratory mice. First, a model was established, using parasite-infected mouse macrophages for rapidly determining the activity of drugs against intracellular amastigotes. Results indicated that recombinant Leishmania can be reliably and confidently used to monitor compounds acting on intracellular amastigote-harbouring macrophages. Secondly, temporal analyses were performed following inoculation of metacyclic promastigotes into the ear dermis of BALB/c mice and the bioluminescent light transmitted through the tissue was imaged externally using a charge coupled device (CCD) camera. Bioluminescent signals, measured at the inoculation site and in the draining lymph node of mice containing these parasites correlated well with the more classical quantification of parasites. These assays prove that the real-time bioluminescent assay is not only sensitive but also more rapid than culture-base techniques allowing to monitor parasite-load before any clinical signs of leishmaniasis are detectable. In short, this luciferase imaging study is useful to monitor the efficacy of anti-leishmanial drugs on live cell culture and to trace leishmanial infection in animal models.
Lang
Thierry
T
Unité d'Immunophysiologie et Parasitisme Intracellulaire, Département de Parasitologie, Institut Pasteur, rue 25 du Dr Roux, 75724 Paris cedex 15, France. tlang@pasteur.fr
Goyard
Sophie
S
Lebastard
Mai
M
Milon
Geneviève
G
D000818:Animals; D001854:Bone Marrow Cells / Q000187:drug effects / Q000378:metabolism / Q000469:parasitology; D002478:Cells, Cultured; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D005260:Female; D007891:Leishmania / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology*; D007896:Leishmaniasis / Q000469:parasitology / Q000473:pathology; D049409:Luciferases, Firefly / Q000096:biosynthesis*; D008163:Luminescent Measurements; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism / Q000469:parasitology*; D051379:Mice; D008807:Mice, Inbred BALB C; D014162:Transfection; D014344:Trypanocidal Agents / Q000494:pharmacology*
D014344:Trypanocidal Agents; D049409:Luciferases, Firefly